Research & Education
A verified library on Breast Implant Illness (BII). Every resource carries an evidence label so you always know what kind of source you're reading, links to its original source, and states plainly what it does — and does not — prove.
Short orientation guides from the Tracker. These are educational — not primary sources — and cite authoritative sources for any medical facts.
How to walk into an appointment organized — with your timeline, symptoms, and implant records in one place — so your time with the clinician goes further.
Read guide →Tracker GuideA starting set of questions you may want to discuss with a qualified, board-certified surgeon — about your implants, the procedure, and follow-up.
Read guide →Tracker GuideA plain-language glossary of the words you'll hear when researching implant removal — explant, capsule, the types of capsulectomy, and rupture — with no claim that any approach is required.
Read guide →Verified external sources, each carrying an evidence label and a link to its original.
Information published by regulatory bodies such as the U.S. FDA.
Published, peer-reviewed scientific literature.
Guidance from authoritative medical or professional societies (e.g., ASPS).
Observational, community-reported experience. Does not establish incidence, prevalence, or causation.
Filter by topic
The FDA's overview of the known risks of breast implants — from local complications to the systemic symptoms some people call breast implant illness. It states plainly that these systemic symptoms, and what causes them, are still poorly understood.
The FDA's pre-decision guidance: breast implants are not lifetime devices, additional surgeries are likely over time, and a patient decision checklist should be reviewed with your provider.
The FDA's page on breast implant surgery — including the boxed warning and the patient decision checklist that must be reviewed and signed with your provider before surgery, plus questions to ask your surgeon.
The FDA's Q&A on BIA-ALCL — a lymphoma of the immune system (not breast cancer) that can develop in the scar tissue and fluid around an implant, with higher risk for textured implants.
An FDA safety communication about reports of cancers — squamous cell carcinoma and various lymphomas — found in the capsule around breast implants. These are different from BIA-ALCL, and the reported condition appears rare with the evidence still developing.
The FDA's plain-language consumer overview: breast implants are not lifetime devices, they carry known risks including systemic symptoms some call breast implant illness, and a signed patient decision checklist is required before surgery.
Community insights will appear here as the BII Tracker participant cohort grows. We never publish example or manufactured numbers — this section stays empty until real, consented, de-identified data exists.
Breast Implant Illness Tracker provides education and organizational tools only and does not provide medical diagnosis or treatment.